Background: Phosphoantigen was originally identified as the main cd TCR-recognized antigen that could activate cd T cells to promote immune protection against mycobacterial infection. However, new evidence shows that the cd T cells activated by phosphoantigen can only provide partial immune protection against mycobacterial infection. In contrast, whole lysates of Mycobacterium could activate immune protection more potently, implying that other cd TCR-recognized antigens that elicit protective immune responses. To date, only a few distinct mycobacterial antigens recognized by the cd TCR have been characterized.
Introduction
Approximately 2 billion people worldwide are infected with M. tuberculosis and around 3 million deaths occur annually due to this disease. Several immune protective mechanisms are involved in controlling the infection of M. tuberculosis including cytokine release and effector functions of immune cells. cd . T cells, a subset of immune cells, play important roles in host immunity as a bridge between innate and adaptive immunity. In recent years, increasing amounts of research have concentrated on the immune protective function of cd T cells in M. tuberculosis infection [1] [2] [3] [4] . However, the mechanisms by which cd T cells recognize tuberculosis antigens remain unclear and little is known about the distinct tuberculosis protein antigens that can effectively activate cd . T cells.
cd . T cells recognize a variety of antigens. The best-known antigens for cd . T cells are phosphoantigens, such as pyrophosphoantigen, aminobisphonate, and alkylamine [5] [6] . With the progress of research in cd T cells, additional protein antigens recognized by cd T cells are being identified continually. MHC class I chain-related gene A (MICA) and B (MICB) were recognized by Vd1 cd . T cells [7] . UL-16 binding protein 4 (ULBP4) was shown to be a novel ligand for c9/d2 T cells [8] . The results of Chen et al. [9] suggested that human mutS homolog 2 (hMSH2) might be a new ligand for the cd TCR. Moreover, other protein antigens, such as ectopically expressed mitochondrial ATPase [10] , were identified as ligands for the cd TCR.
cd T cells recognize M. tuberculosis antigen and promote immune-protection against mycobacterial infection. Originally, phosphoantigen was regarded as the main cd TCR-recognized antigen that activated cd T cells. However, phosphoantigenactivated cd T cells display a restricted TCR diversity and only a subset of phosphoantigen-responsive cd T cells mediate protective immunity against tuberculosis [11] . In contrast, whole lysates of Mycobacterium activate immune protection more potently, implying that other cd TCR-recognized antigens in Mycobacterium also elicit protective immune responses [4] . Boom et al. showed that protein antigens with a molecular mass of 10-14 kDa in the supernatant from heat-treated Mycobacterium functioned as bioactivators that stimulated cd T cells [12] . The protein antigens of M. tuberculosis effectively activated cd T cells, which in turn induced innate and adaptive immunity to M. tuberculosis. At the same time, cd . T cells participated in the anti-tuberculosis immune response elicited by other immune cells [13] [14] [15] [16] . The interaction net composed of many types of immune cells plays an important role in the control of M tuberculosis. However, up to now, ESAT-6 [17] is the only tuberculosis protein antigens identified to be recognized by cd TCR.
Recently, a novel strategy that used intact cells as probes to pan target peptides in a phage-display library was developed [18] [19] . Using the hepatocellular carcinoma cell line HepG2 as a probe, Zhang et al. obtained a target peptide HCBP1 that may be a potential candidate for targeted drug therapy for liver cancer [20] . To identify mycobacterial antigen, Alderson et al. developed a technique using Mycobacterium-specific CD4
+ T cells to screen a mycobacterial genomic library. The direct identification of antigens using T cells would undoubtedly be critical to detect unknown antigens in Mycobacterium [21] . Their research inspired us to develop a novel strategy to screen a phage-display library using cd T cells cultured in vitro. To obtain cd T cells purely by in vivo culture was infeasible due to the difficulty in culturing these cells and the limited quantity of cd T cells. We addressed these problems by transfecting cells with specific cd TCR. After the fulllength c chain and d chain were co-transfected to J.RT3-T3.5 cells, a T-lymphoma cell line deficient in both TCR a/c and b/d chains (ATCC), the transfected cells with homogeneous cd TCR were used as cd T cells to analyze the recognition mechanism of cd TCR to antigens [8, 22, 23, 24] and to identify the antigens recognized by cd T cells [8] . In addition, while the antigen binding site of the cd TCR is primarily formed from 3 CDRs contributed by each Vc or Vd domain, the sequence diversity in antigen receptors is highly concentrated in 1 or 2 CDR3s [9] . Based on known CDR3 sequences of cd T cells, we generated cell lines expressing specific cd TCR, which may be used as a probe to pan antigen peptides recognized by cd TCR.
In this study, the BCG-specific cd TCR-expressing cell lines (tester) and non-specific cd TCR (driver) were used to carry out subtractive screening in vitro with a phage display 12-mer peptide library. After 4 rounds of panning, there was an obvious enrichment for the phages specifically binding to the cd TCR. A group of peptides capable of specifically binding to the cd TCR was obtained. After functional tests and bioinformatics analyses, we identified a target peptide (BP3) that could be recognized by the cd TCR and activate cd T cells from human subjects inoculated with BCG. Importantly, we demonstrate that oxidative stress response regulatory protein (OXYS) that contains the identified peptide could be recognized by cd TCR and activate cd T cells from human subjects inoculated with BCG.
Results
Construction of the transfected cells expressing BCG specific cd . TCR (BCG cd T cells) and BCG non-specific cd TCR (DBS4.3 cd T cells)
As reported by Spencer [11] , the dominant BCG specific c9 CDR3 sequence in human is LWEVISELGKKIK and d2 CDR3 is ACDTVGSYVPTGETDKL. Accordingly, we designed the overlapping forward and reverse primer (supporting information table S1) containing the nucleic acid sequences encoding the above peptides to substitute the original CDR3 region by using overlapping PCR. The PCR products of the full-length c9 and d2 chains are shown in Figure 1B . These PCR fragments were then cloned into pREP7 and pREP9 expression vectors and cotransfected into J.RT3-T3.5 cells by electroporation. After selection and FACS analysis, ,40% of the transfected cells were shown to express the c9/d2 TCR ( Figure 1C ). We chose a known human cd T cell clone, DBS4.3 cd T cells to be the BCG nonspecific cd TCR control. The c9 and d2 CDR3 sequences of DBS4.3 are LWEWELGKKIK and ACDTLVSTDKL [26] , respectively ( Figure 1A ). The cells expressing DBS4.3 cd TCR were constructed using a similar procedure. Forty percent of the cells expressed the c9/d2 TCR. The transfected cells were enriched by flow sorting ( Figure 1C) . To check the BCG specificity of the transfected cd TCR, the cells expressing BCG-specific and non-specific cd TCR were stimulated with protein extracts of BCG and the level of secreted IL-2 was measured by ELISA. As shown in Figure 1D , the protein extract of BCG stimulated the BCG-specific cd T cells and induced much more IL-2 than the DBS4.3 cd T cells, suggesting that J.RT3-T3.5 transfected cells expressing BCG-specific cd TCR were successfully generated.
Biopanning of BCG cd . TCR recognized peptides from phage library using the transfected cells
To identify the epitopes recognized by BCG-specific cd . TCR, we performed a cd TCR cell-mediated biopanning of a 12-mer random peptide phage-display library. The experimental procedure is shown in Figure 2A . Phages specifically binding to BCGspecific cd TCR were identified through 4 rounds of in vitro panning. After 4 rounds of in vitro selection and enrichment, the number of eluted phages increased 4000 fold (from 5.8610 4 pfu to 2.4610 8 pfu) compared to that of the phages in the first round ( Table 1 ). The output/input ratio of phages after each round of panning was used to determine the phage recovery efficiency and an obvious enrichment of phages specifically binding to BCG cd T cells was found (Table 1) . By analyzing the results of phage-ELISA ( Figure 2B ), 30 phage clones specifically binding to the BCGspecific cd T cells (the ratio of specific binding to nonspecific binding was more than 2) were amplified by RT-PCR ( Figure 2C ). The RT-PCR products were sequenced using the specific sequencing primer provided from the kit and the results are shown in Table 2 . Three prominent peptides were selected as candidates for further functional study based on their high frequency of appearance among the 30 sequences. These three peptides were designated as BP1, BP2, and BP3 respectively and then chemically synthesized for further use.
Confirmation of peptide binding to the BCG specific cd TCR transfected cells
Binding assays and blocking assays were performed to determine whether the synthesized peptides specifically bind to BCG-specific cd TCR, using ELISA and FACS. We first examined IL-2 production after the transfected cells were stimulated by the 3 putative peptides. All 3 peptides could stimulate BCG-specific cd T cells to secrete IL-2 in a dosedependent manner. Importantly, the IL-2 production of the BCGspecific cd T cells stimulated by BP3 could be significantly blocked by functional cd TCR blocking monoclonal antibody at some dosages, suggesting that the binding between BP3 and the BCGspecific cd TCR transfected cells was specific ( Figure 3A) . The binding of transfected cells with peptides was further confirmed by FACS analysis. Although BP1, BP2, and BP3 all bound to BCGspecific cd T cells, only the binding of BP3 could be blocked by functional cd TCR blocking monoclonal antibody ( Figure 3B ).
These results suggest that BP3, as a candidate epitope peptide, specifically bound to BCG-specific cd T cells.
Binding and activation of cd T cells from human subjects inoculated with BCG by epitope peptides in vitro Since BP3 could specifically bind the BCG-specific cd T cells, we infer it might contain a cd TCR recognized epitope. A binding assay and amplification assay were performed, using PBMC isolated from human subjects inoculated with BCG or uninoculated subjects, to investigate whether natural cd T cells could recognize and become activated by the epitope peptide. Fresh PBMC were immobilized with anti-pan cd TCR monoclonal antibody in 24-well culture plates with RPMI 1640 medium for 2 weeks to obtain enough numbers of cd T cells. Flow cytometry was performed to analyze the binding capability of biotinylated BP3 with enriched cd T cells from BCG vaccinated subjects and un-vaccinated subjects. Thirty-three percent of cd T cells from human subjects inoculated with BCG bound to BP3; whereas only 5% cd T cells from human subjects un-inoculated with BCG bound to BP3 ( Figure 4A ). In addition, immobilized BP3 were able to induce expansion of cd T cells in PBMC from human subjects inoculated with BCG to an average 18% after coculture for 2 weeks, significantly higher than the expansion to 6% cd T cells in PBMC from human subjects un-inoculated with BCG ( Figure 4B ). The proliferation of cd T cells expanded by BP3 peptide was further confirmed by the CCK-8 assay ( Figure 4C ). Taken together, these data demonstrate that the candidate epitope BP3 could bind and activate cd T cells from human subjects inoculated with BCG in vitro.
The immune functions of cd . T cells from human subjects inoculated with BCG induced by peptide BP3
We determined the immune functions of cd T cells from human subjects inoculated with BCG induced by peptide BP3 using cytokine production and cytotoxicity assays. A strong enhancing effect on Th1 cytokine (IFN-c and TNF-a) production, but not Th2 cytokine (IL-4 and IL-10) production, was observed in cd T cells from subjects inoculated with BCG and expanded by BP3 ( Figure 5A ). Then, we examined the cytotoxicity of cd T cells induced by peptide to THP-1 cells infected by BCG. cd T cells induced by peptide BP3 had a cytotoxic effect on THP-1 cells infected by BCG ( Figure 5B ).
BLAST analysis
BLAST search was performed to identify motif-containing mycobacterial proteins in the sequences of 3 peptides. BLAST results are listed in Table 3 . The peptide BP3 had the best matching characteristics to protein in Mycobacterium, with an E value of 39.2. The matching protein of BP3 was oxidative stress response regulatory protein (OXYS) in M. tuberculosis K85, M. tuberculosis CPHL_A and LysR family of transcriptional regulator in M. tuberculosis KZN 4207. Moreover, another BLAST analysis in all species demonstrated that there were no significant matches with other proteins. Meanwhile, further BLAST analyses confirmed that OXYS protein also exists in M. bovis BCG str. Pasteur 1173P2. It is conserved in BCG and many mycobacteria. Combining the above experimental results and bioinformatics analyses, the BP3 peptide was regarded as a promising candidate epitope peptide, which was recognized by the cd TCR. In addition, OXYS protein was regarded as a candidate antigen recognized by the cd TCR and selected for further analysis.
The OXYS protein binds and activates cd T cells in vitro
To date, there have been some controversies about whether cd T cells could recognize intact protein, the recognition mechanism of cd T cells to antigen remains uncertain. Although our study demonstrated BP3 could bind and activate cd T cells, we had not yet determined whether its matched protein could be recognized by cd T cells. To answer this question, we examined the binding activity of OXYS protein to transfected cd T cells, as well as its ability to activate natural cd T cells. We expressed the full-length OYXS protein with His tag in E. coli. The purification of OXYS protein was determined by SDS-PAGE ( Figure 6A ) and western blot with anti-His tag mAb ( Figure 6B ). The IL-2 secretion from BCG-specific cd T cells and DBS4.3 cd T cells after stimulation with purified OXYS protein at different concentrations was examined. Production of IL-2 in BCG-specific cd T cells increased in a dose-dependent manner after simulation with OXYS protein ( Figure 6C ). Furthermore, exposure to OXYS protein induced expansion of cd T cells in PBMC from human subjects inoculated with BCG to an average of 16% after co-culture for 2 weeks, significantly higher than the 6% cd T cells in PBMC from human subjects un-inoculated with BCG ( Figure 6D ). The proliferation of cd T cells expanded by OXYS protein was confirmed by the CCK-8 assay ( Figure 6E ). These data confirmed that OXYS protein expressed in E. coli could specifically bind to the cd TCR, and activate cd T cells from human subjects inoculated with BCG, suggesting cd TCR might recognize intact protein as antigens.
Discussion
In this study, we developed a novel strategy to identify epitopes and protein antigens recognized by cd T cells by combining immunological and biochemical methods. With this strategy, we identified a promising cd T cell-reactive BCG-specific epitope (peptide BP3) and one candidate BCG protein recognized by cd T cells (protein OXYS). BCG-specific cd TCR transfected cells could bind the peptide and could stimulate the expansion of cd T cells from human subjects inoculated with BCG. Moreover, the BP3 matched mycobacterial protein OXYS was also bound by the BCG-specific cd TCR transfected cells and in vitro, activated the cd T cells from human subjects inoculated with BCG.
Previously, the cd TCR transfected cells were used to evaluate the roles of some amino acids in antigen recognition [24] [25] [26] [27] [28] . This system could also be used to screen the antigens recognized by cd T cells. Kong et al. [8] identified a cd TCR recognized protein ULBP4 using the specific cd TCR transfected cells. In our study, we first applied the transfected cells as probes to pan the phage library for screening of the epitopes recognized by cd TCR. Prior to the panning process, we constructed the BCG-specific cd TCRtransfected cells as tester cells and non-specific cd TCRtransfected cells as driver cells. We performed 4 rounds of in vitro subtractive panning on tester and driver cells and developed some optimizing procedures to improve the probability of obtaining specific phages with high affinity. The binding specificity of BP3 and OXYS to the cd TCR and their ability to activate transfected cell lines and natural cd T cells proved the success of this method. The new method can be used to detect additional protein antigens recognized by cd T cells in the future.
A potential problem of our research is the representativeness of the CDR3 sequences we used. The CDR3 sequences in BCGexpanded c9/d2 cells were obtained according to Spencer's report [11] . About 60% of the BCG-expanded c9/d2 cells contained the CDR3 sequence. Thus, the identified epitopes and proteins using cells transfected with this CDR3 sequence as a probe were specific to this subset of c9/d2 cells. However, due to the diversity of CDR3 sequences, the reported CDR3 sequence might not be the dominant sequence in different areas, people, or races. Therefore, the CDR3 sequence applied in our study might not be representative for all c9/d2 cells from human subjects inoculated with BCG, and the epitopes and proteins determined by this screening method might not fully represent antigens recognized by cd T cells from human subjects inoculated with BCG. That might be the reason why peptide BP1 and BP2 could neither specifically bind to the transfected cell line expressing BCG-specific cd TCR ( Figure 3B ), nor effectively activate cd T cells isolated from human subjects inoculated with BCG (data not shown), even though they have a higher frequency of occurrence ( Table 2) .
As shown in figure 3A , all 3 peptides could stimulate more IL-2 production by DBS4.3 cd T cells than control peptides. We believe it depends on the difference of DBS4.3 cd TCR and BCG cd TCR. Both TCRs differ only in the CDR3 sequence. They have common CDR1, CDR2, and fragment regions. Therefore, during the screening procedure, we did not guarantee that all peptides that partially bind driver cells and tester cells could be excluded. Although BP1, BP2, and BP3 could bind to BCGspecific cd T cells and DBS4.3 cd T cells, only the binding of BP3 to cells could be blocked by a functional cd TCR blocking monoclonal antibody.
In this study, we identified one epitope peptide recognized by BCG-specific cd TCR by screening the phD 12 phage-display peptide-library, but more peptide candidates probably remain unidentified. The phD 12 phage-display peptide-library was based on a combinatorial library of random peptide 12-mers fused to a minor coat protein of M13. The library contained a complexity of 2.7610 9 individual clones, representing the entire obtainable repertoire of 12-mer peptide sequences, which expresses a random 12 amino acid sequence. However, it still might not fully cover the sequence of BCG or Mycobacterium. More epitopes for the BCGspecific cd TCR may be identified by screening the random expression genomic library of Mycobacterium.
The OXY protein identified as a cd TCR recognized antigen according to this strategy, is a protein with a molecular mass of 44 kDa. This differs from the results of Boom, who found that protein antigens with a molecular mass of 10-14 kDa in the supernatant from Mycobacterium tubercolosis were a major stimulus for human cd T cells [12] . However, the results of Boom did not exclude the possibility that other molecular mass of proteins may have an activation function for cd T cells as well. According to our strategy, a distinct cd T cell-recognized antigen was identified. Therefore, different screening methods may be complementary to each other to explore new protein antigens recognized by the cd TCR.
We compared cd T cells expanded by BP3 peptide or OXYS protein obtained from un-vaccinated persons and BCG vaccinated persons. The results showed that immobilized BP3 was able to induce the expansion of cd T cells in PBMC from human subjects inoculated with BCG to an average 18%, significantly higher than the 6% expansion of cd T cells in PBMC from human subjects uninoculated with BCG. Meanwhile, OXYS protein was able to induce expansion of cd T cells in PBMC from human subjects inoculated with BCG to an average 16%, significantly higher than the 6% expansion of cd T cells in PBMC from human subjects uninoculated with BCG. In addition to assessing the proliferation of cd T cells by percentages, we also used the CCK-8 assay to detect the proliferation of cd T cells. Cell Counting Kit-8 allows sensitive colorimetric assays for the determination of the number of viable cells in cell proliferation and cytotoxicity assays. CCK-8 was reduced by dehydrogenases in cells to give a yellow colored product (formazan), which is soluble in the tissue culture medium. The amount of the formazan dye generated by the activity of dehydrogenases in cells is directly proportional to the number of living cells. So according to the change of the absorbance, the data did show the proliferation of BP3 and OXYS stimulated cd T cells.
In conclusion, our results provide new insights about cd T cells and BCG antigen from 3 aspects. First, we provided a novel strategy to identify epitopes and proteins recognized by cd TCR. The new strategy could be expanded to the use of detecting other protein antigens recognized by cd T cells. Second, our findings added to the understanding of the recognition mechanism of cd TCR to protein antigens. Third, the peptide BP3 or OXYS protein were identified as potential candidate peptides or antigenic components to develop new tuberculosis vaccines or adjuvant, as well as biomarkers of tuberculosis infection. Further studies are in progress to confirm the bio-function of the target peptide and OXYS protein in anti-tuberculosis infection.
Materials and Methods

Ethics Statement
This work received approval from the Clinical Ethics Committee of the Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College. All subjects gave their informed consent to participate. The consent was verbal. The ethics committee specifically approved that procedure.
Subjects
Twenty volunteers composed of 12 men and 8 women aged 15 to 32 years were enrolled in this study. Of these, 15 subjects were vaccinated with BCG and 5 subjects were not vaccinated with BCG. Exclusion criteria for all subjects were smoking, medication, pregnancy and any abnormalities in renal and liver function tests. 
Reagents and cell lines
The phD 12 phage-display peptide-library kit (New England Biolabs, USA) was used to screen specific peptides binding to cd TCR. The titer of the library is 2610 13 pfu. The E. coli host strain ER2738 was used for M13 phage propagation. J.RT3-T3.5 cells and THP-1 cells, a human myelomonocytic cell line, were obtained from the American Type Culture Collection (ATCC). These cells and the transfected cells derived from them were maintained in RPMI-1640 supplemented with 10% FCS, penicillin, streptomycin, and 5610 25 M b-mercaptoethanol. cd T cells were obtained from fresh peripheral blood mononuclear cells (PBMC) by immobilization by anti-pan-cd TCR monoclonal antibody (Immunotech). In brief, PBMC was separated from peripheral blood by density gradient centrifugation on FicollHypaque (GE Healthcare). The cells were grown in RPMI 1640 medium supplemented with 12% FCS, 200 U/mL IL-2, penicillin, streptomycin, and 5610
25 M b-mercaptoethanol, in a 24-well cell culture plate containing immobilized anti-pan-cd TCR monoclonal antibody at 37uC in 5% CO 2 . Every 3-4 days, half of the medium was discarded and replenished by fresh medium and cytokines. After 2 weeks of culture, the viability of cells assessed by flow cytometry using 7AAD stain was more than 90%. The purified cell population contained about 80% viable cd T cells.
Construction of transfected cells expressing BCG-specific and non-specific cd . TCRs
A full-length c9 or d2 chain was amplified from PBMC cDNA using specific primers containing KpnI and XhoI restriction sites. The BCG-specific CDR3 sequence was inserted into full-length c9 and d2 chain to substitute for the original CDR3 sequence using overlapping PCR. The full-length TCR chain with BCGspecific CDR3 sequence was digested with KpnI and XhoI and cloned into pREP7 and pREP9 expression vectors with either hygromycin or neomycin resistance. Meanwhile, full-length pREP7-c9 and pREP9-d2 chains of DBS4.3, a known cd T-cell clone, with a different c9 and d2 CDR3 sequence than the BCGspecific cd TCR, was also constructed according to same procedure, as a non-BCG specific control. The J.RT3-T3.5 cells (1. 2610 7 ) were co-transfected with 20 mg of pREP7-c9 and pREP9-d2 by electroporation at 260 V and 975 mF using BioRad Gene-Pulser. After 48 h, the transfected cells were cultured in selection medium with hygromycin and neomycin for 4 weeks. After the cd T cells expanded by peptide were isolated by flow sorting, they (1610 5 /100 ml) were inoculated into a 96-well plate immobilized with different dosage of peptide and incubated for 4 hours. CCK-8 reagent (10 ml) was added to each pore and continued to culture for 4 hours until the media turned yellow. The absorbance value (450 nm) of each pore was measured using a microplate reader. Data are shown as the mean of three independent experiments. doi:10.1371/journal.pone.0018809.g004
In vitro panning
The transfected cells expressing BCG-specific cd TCR (named BCG cd T cells) were used as tester cells, and the transfected cells expressing DBS4.3 cd TCR (named DBS4.3 cd T cells) were used as the driver cells for subtractive screening from a phage-display 12-peptide library. The driver cells were washed with phosphate buffered saline (PBS) and kept in serum-free RPMI-1640 for 1 h before blocking with 3 mL blocking buffer (5% bovine serum albumin (BSA) in PBS) for 30 min at 37uC. Approximately 2610 11 pfu phages were added to the blocked driver cells and mixed gently for 1 h at 37uC. The cells were then pelleted by centrifugation at 800 rpm for 5 min. The supernatants containing the phages were incubated with the blocked tester cells for 1 h at 37uC before the cells were pelleted again. The cells were washed twice with 0.1% TBST (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Tween-20) to remove unbound phage particles. The tester cells and bound phages were both incubated with E. coli host strain ER2738 and the phages were rescued by infection with bacteria when the cells died. The phage titer was subsequently evaluated by a blue plaque-forming assay on agar plates containing tetracycline. Finally, a portion of purified phage preparation was used as the input phage for the next round of in vitro selection. In total, 4 rounds of selection were taken. For each round of selection, 2610 11 pfu of collected phages were used. The panning intensity was increased by prolonging the phages incubation process with driver cells to 1.25 h, 1.5 h, and 2 h and by shortening the process with tester cells to 45 min, 30 min, and 15 min in the second, third, and fourth rounds of selection, respectively. Meanwhile the number of TBST washes was increased to 4, 6, and 8 times in the second, third, and fourth rounds of selection, respectively.
Identification for phage clones binding to transfected cells by phage-ELISA, PCR and sequencing
The tester cells and driver cells were seeded into 96-well plates (1610 5 cells/well) one day before use and then fixed in 96-well plates, with 4% formaldehyde for 15 min at room temperature. The plates were washed 3 times with PBS. The amplified phage clones were then picked out randomly and blocked individually with 1% BSA at 37uC for 30 min. These phage clones were added into the tester and driver cells (1610 10 pfu/well) and incubated at 37uC for 2 h. The plates were washed 3 times with PBS, and then the mouse anti-M13 phage antibody was added at a dilution of 1:1000 in TBST and incubated at 37uC for 1 h. After reaction with HRP-conjugated goat anti-mouse IgG antibody (eBioscience) and substrate (Sigma), the plates were read on a microplate reader (SpectraMax M5) at 450 nm. As negative controls, PBS and unrelated phages with the same titer were used. The positive phage clones in ELISA were amplified by PCR, and the parts containing epitopes were sequenced using the 3730 sequencer with the sequencing primer, 59-CC CTC ATA GTT AGC GTA ACG-39 (supplied in the kit).
Peptide synthesis and labeling
After in vitro screening and sequencing confirmation, 3 candidate peptides BP1, BP2 and BP3 were selected for further analysis and were synthesized in the peptide synthesis facility of the Academy of Military Medical Sciences, China. The purity of synthesized peptides was more than 90% in HPLC analysis. Half of the synthesized peptides were labeled with biotin at their N terminal ends.
Protein expression and preparation of BCG soluble extracts
Purified oxidative stress response regulatory protein (oxyS, Rv0117) PCR fragments amplified from H37Rv genomic were digested with KpnI and XhoI enzymes and linked into prokaryotic expression plasmid pET30a. Freshly transformed E. coli BL21 (DE3) cells harboring plasmid pET30a-oxyS were cultured in 500 mL of LB medium containing kanamycin at 37uC. When the cell density reached 0.8-1.0 (OD600), isopropyl-b-D-thiogalactopyranoside (IPTG, Sigma) was added to a final concentration of 1 mM, and the bacteria were cultured for another 3 h at 37uC. The culture was then harvested and centrifuged at 50006g for 15 min at 4uC. The inclusion body was dissolved in 8 M urea and then purified with Amersham Biosciences HisTrap column. The His-tagged protein molecular weight and purity were confirmed by SDS-PAGE on 12% acrylamide gels and western blot. The BCG bacteria were heat inactivated at 85uC for 20 min, and then the bacteria were subjected to 5 h of sonification at room temperature in a water bath sonicator. The extracts were then spun at 130006g for 5 min and the supernatants were collected.
Binding of J.RT3-T3.5 transfectants to peptides and proteins
The transfected cells were pre-incubated with 10 ng/mL Phorbol Myristate Acetate (PMA) at room temperature for 30 min. After extensive washes with RPMI-1640, the cells were plated into 24-well plates at 10 6 per well in the presence of 3 peptides, control peptide, OXYS protein, control protein or BCG soluble extracts. The supernatants were harvested after 24 h and the level of IL-2 was detected using the Human IL-2 ELISA Kit (B.D.Company) according to the manufacturer's instructions. The binding of transfected cells to peptides was also detected via flow cytometry. The cells were incubated with biotin-conjugated peptide or control peptide and FITC-conjugated streptavidin (eBioscience) was added, and the cells were incubated for 30 min at 4uC. The cells were then analyzed by flow cytometry. Peptide/protein-immobilized amplification assay PBMC from subjects vaccinated with BCG and un-vaccinated subjects were immobilized with peptides or OXYS protein for the amplification assay. The PBMC were cultured in RPMI 1640 medium with 10% FCS and IL-2 (200 U/mL) for 2 weeks and then the percentage of cd T cells was measured by FACS analysis. The positive cd T cells were isolated by flow sorting for further functional experiments.
Determination of cd T cells proliferation
The proliferation of cd T cells was detected by the Cell Counting Kit-8 (CCK-8) assay (KeyGEN). After the cd T cells expanded by peptide and protein immobilization were isolated by flow sorting, 1610 5 /100 mL were inoculated into a 96-well plate, immobilized with different dosages of peptide/protein, and incubated for 4 h. CCK-8 reagent (10 mL) was added to each well and culture was continued for 4 h until the media turned yellow. The absorbance value at 450 nm of each well was measured using a microplate reader (SpectraMax M5).
Cytokine production
After the cd T cells activated by BP3 peptide were sorted, the production of cytokines IL-4, IL-10, TNF-a and IFN-c were determined by ELISA according to the manufacturer's instructions.
MTT cytotoxicity
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric test was used to evaluate the cytotoxic effects of cd T cells on THP-1 cells infected with BCG in vitro. The BCG strain was grown in Middlebrook 7H9 liquid medium (Invitrogen) with 10% albumin/dextrose-catalase (ADC) enrichment media (sigma) supplemented with 0.2% glycerol. THP-1 cells were infected with BCG strains at a multiplicity of infection (MOI) of approximately 10 bacterial cells per macrophage. THP-1 cells infected by BCG were used as target cells and seeded into 96-well plates at 10 4 cells per well. The cd T effector cells were added to each well with an appropriate ratio of effector cells and target cells. After the effector cells and the target cells were incubated at 37uC for 4 h, 15 mL of MTT solution (5 mg/mL) was added to each well, and incubated at 37uC for an additional 4 h. The reaction was stopped by the addition of 100 mL dimethyl sulfoxide to dissolve the tetrazolium crystals. The plate was examined at 570/ 630 nm on a microplate reader (SpectraMax M5) and the percentage of specific lysis was calculated.
Bioinformatics analysis
Homologous analysis and sequence alignment were done using BLAST (Basic Local Alignment Search Tool) programs to determine matched protein of related peptides. In the NCBI website http://www.ncbi.nlm.nih.gov/blast, the program of protein BLAST was selected for bioinformatics analysis. The amino acid sequences of BP1, BP2, and BP3 were input, the nonredundant protein sequence (nr) was chosen in the database and the organism was limited to Mycobacterium. Three matched proteins with higher scores were listed. To demonstrate that the matched protein was specific for Mycobacterium, we performed another blast analysis in which the organism was limited in all species.
Statistical analysis
Statistical comparisons were performed using the Student's t test. A value of P,0.05 was considered statistically significant. In BLAST analysis, the corresponding E-value for each score was computed. The smaller the E-value, the greater the belief that the aligned sequences are homologous. Table S1 The sequences of specific primers used to produce full length BCG-specific and DBS4.3 c9/d2 chains are listed in this file. (DOC)
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